LegalCaseDocs.com
shopping cart  
  |     
Search
 

 
New Visitors


 VeriSign Secure Site

 Get Adobe Reader

BAXTER PHARMACEUTICAL PRODUCTS v ESI LEDERLE Click to find out why . . .



Keywords & Phrases
CaseNo: C.A. No. 16,863, Plaintiff: BAXTER PHARMACEUTICAL PRODUCTS, State: DE Delaware, UniqueCaseRef: DE>CC>00016863, CourtCode: CC, CourtName: IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE, Pharmaceutical Products, Es1 Lederle, Baxter, Agreement, Ohmeda, Lederle, Contract, Preliminary Injunction, Distribution Agreement, Termination, Acquisition, Assignment, Delaware, Manufacturing, Stock, Stock Purchase, Baxter Healthcare, Anesthesia, Parties, Anti-assignment Clause, Remedy, Language, Irreparable Harm, Non-assignment Provision, Irreparable Injury, Del, Star Cellular, Injunctive Relief, Sales, Baxter Ppi, Ohmeda Pharmaceutical Products, Corporate Transaction, Terminate , ContentID: 120241024

Case Documents
1 1999-02-24 REPLY MEMORANDUM
[ see first page and extracted highlights below  ] ItemID: 103014
20 pages
PDF
2 1999-02-22 DEFENDANTS ANSWERING BRIEF
[ see first page and extracted highlights below  ] ItemID: 103012
32 pages
PDF
3 1999-02-17 INC. V. ESI LEDERLE INC. MOTION
[ see first page and extracted highlights below  ] ItemID: 103013
39 pages
PDF
Total Documents: 3 documents , 91 pages
Price: $ 29.95


IVESLCD01 KGI0001
 
 

 Forgot your password?


1 . REPLY MEMORANDUM

EXTRACTED KEY WORDS
PHARMACEUTICAL PRODUCTS
COURT
CONTRACT
BAXTER
ACQUISITION
AGREEMENT
SALES
DELAWARE
STOCK PURCHASE
OHMEDA
CORPORATE TRANSACTION
TERMINATE
PARTIES
ASSIGNMENT
MANUFACTURING
DISTRIBUTION AGREEMENT
NON-ASSIGNMENT PROVISION
DEFENDANT
IRREPARABLE HARM
ES1 LEDERLE FAILS
SALES FORCE
ES1 LEDERLE CONCEDES
INTERPRETATION
FARNSWORTH
MEMORANDUM
BAXTER HEALTHCARE
PAUL THOMAS
NATURE
CHOSE
                    IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

                                     IN AND FOR NEW CASTLE COUNTY


BAXTER PHARMACEUTICAL.
PRODUCTS, INC., a Delaware corporation, f/k/a
OHMEDA PHARMACEUTICAL PRODUCTS
DIVISION INC.,
                               Plaintiff,                        Civil Action No. 16863-NC
                                                                 (JBJ)
           V.

ES1 LEDERLE INC., a Delaware corporation,                        REDACTED
                               Defendant.



                          BAXTER PHARMACEUTICAL PRODUCTS INC.9 REPLY `-;  ~ i' .:
                              MEMORANDUM IN SUPPORT OF ITS MOTION
                                    FOR A PRELIMINARY INJUNCTION


Date of Filing: February 24, 1999                  Phebe S. Young
                                                   THE BAYARD FIRM
                                                   919 Market Street, 16th Floor
                                                   P.O. Box 25 130
                                                   Wilmington, DE 19899
                                                   (302) 655-5000

                                                   Kenneth J. King
                                                   Diane E. Lifton
                                                   Caryn G. Mazin
                                                   BROBECK, PHLEGER & HARRISON LLP
                                                   1633 Broadway, 47th Floor
                                                   New York, New York 100 19
                                                   (212) 581-1600
                                                   Attorneys for Plaintiff
                                                   Baxter Pharmaceutical Products Inc.








NYOLIl3I\Km\
137966  Ol(2YWOl' DOC)
SNIPPETS:
  • IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE
  • OHMEDA PHARMACEUTICAL PRODUCTS DIVISION INC.,
  • BAXTER PHARMACEUTICAL PRODUCTS INC.9 REPLY `-;
  • ES1 LEDERLE MISCHARACTERIZES THE NATURE OF THE CORPORATE TRANSACTION..
  • ES1 LEDERLE WAS ON NOTICE OF THE ACQUISITION, BUT CHOSE TO TERMINATE ONLY WHEN IT HAD DECIDED
  • OHMEDA WAS A COMPETITOR OF ES1 LEDERLE WHEN THE MANUFACTURING AND DISTRIBUTION AGREEMENT WAS
  • THE TESTIMONY OF PHARMACEUTICAL PRODUCTS' FORMER PRESIDENT DOES NOT SUPPORT THAT AN
  • THE NON-ASSIGNMENT PROVISION DOES NOT INCLUDE STOCK PURCHASES.
  • PHARMACEUTICAL PRODUCTS MEETS ITS BURDEN TO SHOW IRREPARABLE HARM.
  • ES1 LEDERLE FAILS TO DEMONSTRATE ANY MATERIAL CHANGES IN THE STRUCTURE OF PHARMACEUTICAL
  • ES1 LEDERLE'S FAILURE TO PERFORM ITS OWN OBLIGATIONS UNDER THE CONTRACT CAUSED SPECIFIC,

  • 2 . DEFENDANTS ANSWERING BRIEF

    EXTRACTED KEY WORDS
    LEDERLE
    AGREEMENT
    BAXTER
    OHMEDA
    TERMINATION
    PRELIMINARY INJUNCTION
    CONTRACT
    ANTI-ASSIGNMENT CLAUSE
    REMEDY
    LANGUAGE
    ACQUISITION
    PARTIES
    IRREPARABLE INJURY
    DEL
    COURT
    BAXTER PPI
    PHARMACEUTICAL PRODUCTS
    DEFENDANT
    ES1
    EXTRAORDINARY REMEDY
    ASSIGNMENT
    STAR CELLULAR
    INJUNCTIVE RELIEF
    BAXTER HEALTHCARE
    VIOLATION
    MONETARY DAMAGES
    STOCK PURCHASE
    CULVER AFF
    IRREPARABLE HARM
    
                      IX THE CICLC'CERY  COCXT OF THE ST-ATE OF DELACVARE
    
                                     IX .4X) FOR >-EW C.I\STLE COLXTY
    
    
     BAXTER  PH;VtLlACEUTICAL  PRODUCTS,
     IXC.. a  DelaLvare corporation,  f?k/a OHMEDA
     PHARMACEUTICAL PRODUCTS DIVISION
     EC.,
    
                               Plaintiff,
    
                      V.                                      C.A. No. 16863-NC
    
    ES1 LEDERLE INC., a Delaware corporation,
    
                               Defendant.
    
    
    
    
                            DEFENDANT'S ANSWERING BRIEF IN OPPOSITION
               TO PLAINTIFF'S MOTION FOR A PRELIMINARY INJUNCTION
    
    
                                                 MORRIS, NICHOLS, ARSHT  &  l-UN-NELL
                                                 Martin P. Tully
                                                 Donna L. Culver
                                                  1201 N. Market Street
                                                 P.O. Box 1347
                                                 Wilmington, DE 19899
                                                 (302) 658-9200
                                                      Attorneys for Defendant
                                                      ES1 Lederle, Inc.
    
    OF COUNSEL:
    
    Lawrence 0.  Kamin
    David M. Stark
    WILLKIE,  FARR  & GALLAGHER
    787 Seventh Avenue
    New York, New York 10019
    (212)728-8000
    
    February 22, 1999
    
    
    
                                       T&ABLE OF CONTENTS
    
    SNIPPETS:
  • BAXTER PH;VtLlACEUTICAL PRODUCTS, IXC..
  • PHARMACEUTICAL PRODUCTS DIVISION EC.,
  • ES1 LEDERLE INC., a Delaware corporation,
  • DEFENDANT'S ANSWERING BRIEF IN OPPOSITION TO PLAINTIFF'S MOTION FOR A PRELIMINARY INJUNCTION
  • PLAINTIFF HAS NOT SATISFIED ANY OF THE ELEMENTS NECESSARY TO -MEET THE HEIGHTENED STANDARD
  • The Language Of The Agreement Is Clear That Plaintiff
  • The Parties Intended The Anti-Assignment Clause To
  • Protect Lederle From Being Forced Into A Partnership
  • That Baxter's Acquisition Of Ohmeda Violated The
  • Plaintiffs Suggestion that No "Assignment'* Can Occur
  • LEDERLE'S TERMINATION OF THE AGREEMENT W-ILL
  • IS CLEAR THAT PLAINTIFF HAS AIN ADEQUATE REMEDY
  • Monetary Damages Are Not Only Calculable And Fully
  • If Baxter PPI Is Unable To Obtain Product From Lederle,
  • Baxter Healthcare Corn v.
  • Consolidated Fisheries Co. v. Consolidated Solubles, Del.
  • amounted to a violation of the anti-assignment clause of the Agreement,
  • Baxter PPI asks this Court to grant the extraordinary remedy of injunctive relief
  • for this alleged breach of contract.
  • the request for injunctive relief must be denied.
  • IcJ.; Culver Aff.
  • irreparable injury, and with full conviction on the part of the court of its urgent
  • 2) that it will suffer irreparable harm if the preliminary injunction is not
  • the defendant if injunctive relief is granted.
  • The applicable standard for analyzing this issue is set forth in Star Cellular
  • Healthcare, and the corresponding delegation of duties, 1s a clear violation of the clause.
  • Plaintiff argues instead that a corporate stock purchase followed by a name-change

  • 3 . INC. V. ESI LEDERLE INC. MOTION

    EXTRACTED KEY WORDS
    ES1 LEDERLE
    BAXTER
    COURT
    DISTRIBUTION AGREEMENT
    MANUFACTURING
    PRELIMINARY INJUNCTION
    CONTRACT
    DELAWARE
    STOCK
    ASSIGNMENT
    ANESTHESIA
    TERMINATION
    PLAINTIFF
    ACQUISITION
    BAXTER HEALTHCARE
    STOCK PURCHASE
    OHMEDA PHARMACEUTICAL PRODUCTS
    NON-ASSIGNMENT PROVISION
    IRREPARABLE HARM
    CONTRACTING PARTY
    STAR CELLULAR
    AUTHORITIES
    PRELIMINARY STATEMENT
    VICE PRESIDENT
    INJUNCTIVE RELIEF
    GPOS
    CONTRACTUAL OBLIGATIONS
    VERIFIED COMPLAINT
    ANESTHESIA-RELATED INJECTABLES
    
                 IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE
    
                                 IN AND FOR NEW CASTLE COUNTY
    
                                                                                        ,
    BAXTER PHARMACEUTICAL                                                               ,_
    PRODUCTS, INC., a Delaware corporation, E/k/a :                               -.
    OHMEDA PHARMACEUTICAL PRODUCTS                  :
    DIVISION INC.,
    
                  Plaintiff,
    
           V.                                              Civil Action No.  16863-NC (JBJ)
                                                           REDACTED
    ES1 LEDERLE INC., a Delaware corporation,       :
    
                  Defendant.
    
    
    
                    PLAINTIFF BAXTER PHARMACEUTICAL PRODUCTS INC.3
                                MOTION FOR A PRELIMINARY INJUNCTION
    
    
    
    
    
    Date of Filing: February 17, 1999            Phebe S. Young
                                                 THE BAYARD FIRM
                                                 902 Market Street, 13th Floor
                                                 P.O. Box 25 130
                                                 Wilmington, DE 19899
                                                 (302) 655-5000
    
                                                 Kenneth J. King
                                                 Diane E. Lifton
                                                 Caryn G. Mazin
                                                 BROBECK, PHLEGER & HARRISON LLP
                                                 1633 Broadway, 47th Floor
                                                 New York, New York 10019
                                                 (212) 581-1600
                                                 Attorneys for Plaintiff
                                                 Baxter Pharmaceutical Products Inc.
    
    
    
                                                                                                     
    
                                                                                                       
    
    SNIPPETS:
  • IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE
  • PLAINTIFF BAXTER PHARMACEUTICAL PRODUCTS INC.3
  • m TABLE OF AUTHORITIES.
  • PRELIMINARY STATEMENT.
  • The Manufacturing And Distribution
  • Pharmaceutical Products, Before and After the Acquisition.
  • ES1 Lederle Had Prior Notice of the Acquisition.
  • Defendant's Breach of the Contract:
  • The Effect of the Agreement's Termination on Existing Contracts,
  • Pharmaceutical Products Meets The Standards For Preliminary Injunction Relief..
  • A Stock Purchase Is Not An Assignment.
  • The Stock Acquisition Was Not An Assignment Under The
  • Pharmaceutical Products Will Suffer Immediate Irreparable Harm
  • Distribution Agreement Will Jeopardize The Existence Of
  • Being Forced To Breach Its Contracts With GPOs and
  •    |